These ASS1-low tumor cells become arginine auxotroph and critically depend on external arginine for survival, which has been exploited therapeutically, using arginine-metabolizing enzymes such as arginase or arginine deiminase (ADI)6. Here, ASS1 is linked to neoplasm.